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Purpose: s: To assess performance of FilmQA Pro software for pre-treatment patient-speciﬁc quality
assurance (QA), using radiochromic ﬁlms and two commercial ﬂatbed scanners. To evaluate a novel
multichannel approach compared to the classical red channel evaluation.
Material and methods: Patient ﬁlms (mostly EBT2 ﬁlms, one box of EBT3) were digitalized using suc-
cessively two ﬂatbed scanners: the A4-size Epson V750 and the A3-size Epson 10000XL. Prior to patient
dose veriﬁcation, basic characteristics of ﬁlms and scanners were investigated. Patient ﬁlms were
analyzed using FilmQA Pro software, which enables to use the signal from all three colour channels (Red,
Green, Blue).
Results: Compared to the red channel evaluation, multichannel evaluation presents better passing rates
with regard to local gamma index. As expected, we obtained better results using A3-size scanner
compared to A4-size scanner, especially when considering large region of interest. An observation of
great interest was made for both scanners: after intensive use, a tilting in the blue transmittance proﬁles
appeared in the lamp direction, making multichannel analysis unsuitable for accurate dose evaluation.
© 2014 Associazione Italiana di Fisica Medica. Published by Elsevier Ltd. All rights reserved.Introduction
Radiochromic ﬁlms are widely used for patient-speciﬁc dose
veriﬁcations. They contain a sensitive continuousmedium and offer
very high spatial resolution. They do not present any volumetric
averaging effect, as opposed to ionization chamber (IC) arrays. In
contrast with diode and chamber arrays, they provide an isotropic
response to radiation and they don't exhibit over-response to low
energy photons owing to their near water equivalency. They can be
irradiated in any position in any (water) phantom and they
generate minimum perturbation of the beam ﬂuence. Moreover,
they are (almost) insensitive to visible light and do not require a
well-controlled wet chemical processing in a dedicated darkroom
facility.
Ashland Inc., Covington, KY, USA (formerly International Spe-
cialty Products) is the only supplier of radiochromic ﬁlms (Gaf-
chromic ﬁlms) dedicated to therapeutic beams dose measurement.
In the early days of 2009, the well-investigated EBT [1e5] was
replaced by the model EBT2 [6e9]. By the end of 2011, a new EBT3
ﬁlm was released [10,11].
Many sources of uncertainties are involved in ﬁlm dosimetry.
Bouchard et al. [5] classiﬁed sources of uncertainties into ﬁveot).
ica. Published by Elsevier Ltd. Allcategories: ﬁlm manufacturing (ﬁlm homogeneity), ﬁlm manipu-
lation (i.e. storage, cutting), ﬁlm irradiation (phantom, setup), ﬁlm
digitalization (ﬂatbed scanner), and ﬁlm response characterization
with absorbed dose (ﬁtting calibration function). Richley et al. [7]
stated that the overall uncertainty in EBT2 ﬁlm dosimetry could
be reduced from 3.8% to 1.5% by correcting for scanner non-
uniformity. Arjomandy et al. [8] observed a 1.8% cumulative un-
certainty arising from single EBT2 ﬁlm non-uniformity, ﬁlm-to-ﬁlm
variation and ﬁtting uncertainty of the calibration data. Sorriaux
et al. [11] emphasized a total uncertainty below 1% in the radio-
therapy dose range (>1.5 Gy) in photon mode using EBT3 ﬁlms.
In this work we compared the “multichannel” analysis available
in FilmQA Pro to the classical single (Red) channel method.We used
successively two commercial ﬂatbed scanners, the Epson V750 A4-
scanner and the manufacturer-recommended Epson 10000XL A3-
scanner. Prior to patient evaluation, some basic characteristics of
both scanners and ﬁlm types were investigated.Materials and methods
Radiochromic ﬁlm and scanner models used
The structure of EBT2 and EBT3 ﬁlms is described in Refs. [10,12].
The same active component is used and the nominal thickness ofrights reserved.
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twofold. First, EBT3 ﬁlm has a symmetric structure, eliminating
concerns about which ﬁlm side should face the scanner glass.
Secondly, in EBT3 ﬁlm the substrates embed microscopic silica
particles in the outer surface, frustrating the formation of Newton
rings. Owing to their atomic composition, EBT2 and EBT3 ﬁlms have
near-tissue-equivalent density (ZEBT2eff ¼ 6:84 compared to
Zwatereff ¼ 7:3). Radiochromic ﬁlms are better stored in a dry and dark
environment. Girard et al. [13] reported a maximum rate of optical
density change of ±0.15% per C in the red channel. They also
showed that relative humidity variations ranging from 80% to 20%
could introduce dose errors of up to 15%. We pre-cut ﬁlms one day
prior to irradiation to allow for disturbances around the edges to
mechanically relax. We do not use gloves and we are careful not to
touch ﬁlm areawhere evaluationwill be performed. From end 2008
to mid-2013, we irradiated 1225 EBT2 ﬁlm sheets (49 boxes) from
12 different lots. We used only one box of EBT3 ﬁlm.
Initially we have been using an Epson A4-size V750 Pro scanner
(Seiko Epson Corporation, Nagano, Japan), thenwemoved to an A3-
size Epson 10000 XL. A technical description can be found in Ref.
[7]. The scanner is used in transmission mode and ﬁlm images are
acquired in 48 bit red-green-blue (RGB) mode at a resolution of
72 dpi (0.35 mm pixel size). In each channel, the maximumvalue of
the analogue-to-digital converter (ADC) scale is 2161 (65,535).
These raw image ADC data are hereafter referred to as “pixel values”
(PV), ranging from 0 (no signal, zero transmission) to 65,535
(maximum signal, total transmission). We use the professional
mode with all image adjustments (such as contrast enhancement)
and colour corrections turned off.
Analysis software
Since 2009 we have been using FilmQA Pro software (Ashland
Inc), a quantitative analysis tool designed for ﬁlm scanning, PV
extraction, PV conversion to dose, and comprehensive dose anal-
ysis. A feature of the software is the ability to use pixel values from
all colour channels together in dose map construction, providing
“corrected” red, green and blue dose maps for further analysis. This
evaluation method is called “triple channel evaluation”, or “multi-
channel evaluation”. According to Micke et al. [14], it allows for the
separation of the dose-dependent part of the signal from the dose
independent-part, the latter stemming from a variety of distur-
bances related to ﬁlm manufacturing (structure heterogeneities) as
well as scanner artefacts (i.e. noise) or ﬁlm manipulation (i.e. dust,
ﬁngerprints). Practically, the method varies the dose values until
the corresponding pixel values are best matched for all three colour
channels. As dose values for the different corrected channels should
be in close agreement, signiﬁcant offsets indicate a mismatch be-
tween the scanned ﬁlm and the calibration data. These offsets are
displayed in so-called “consistency maps”. Clear offsets would occur,
for example, when orientations of calibration ﬁlms and patient
ﬁlms are not the same.
Film irradiation
Film irradiation was performed on two Elekta Synergy S (Elekta
AB, Stockholm, Sweden) linacs equipped with Beam Modulator
collimator. Step-and-shoot IMRT (SS-IMRT) and VMAT treatments
were delivered through 6 MV photon beams exclusively. We used
DMPO and SmartArc modules in Pinnacle v 9.0. (Philips Medical
Systems, The Netherlands). The OmniPro-I'mRT phantom (IBA
Dosimetry AB, Uppsala, Sweden), a modular phantom consisting of
a universal body shaped section made of RW3 material (1.045 g/
cm3) can accommodate pre-cut ﬁlm pieces of 16  16 cm2 between
slabs in a coronal plane. In addition to ﬁlm evaluation, weperformed ionization chamber measurements with a cross-
calibrated CC13 chamber (IBA Dosimetry) ﬁtted at the phantom
geometrical centre. One single ﬁlm per patient, positioned 2 cm
above the isocentre plane, was used. Prior to patient ﬁlm irradia-
tion, a “control ﬁlm” was exposed to an open 10-cm square ﬁeld
(225 cGy at the ﬁlm location).
Film scanning
The reproducibility of ﬁlm positioning is a key point due to the
non-uniform scanner response over the scan ﬁeld. It has been
shown [2,7] that raw pixel values obtained from any scanner
readout are dependent on both the received dose and the ﬁlm pixel
position on the scanner glass, especially in the transverse direction
(the direction perpendicular to the scan direction, or parallel to the
scanner lamp). This well-known artefact, referred to as “lateral ef-
fect”, causes transmission PV to decrease as the lateral distance
from the scan axis increases. This effect increases at high doses. In
this study a template is ﬁtted on the scanner glass so that ﬁlm
pieces are immobilized in the central area of the scanner bed, in a
reproducible way.
Due to the anisotropic light scattering in radiochromic ﬁlms,
ﬁlm orientation must be kept constant. Film orientation is referred
to as “portrait” when the long axis of the ﬁlm is parallel to the scan
direction. The orientation perpendicular to the portrait orientation
is referred to as “landscape” orientation. According to the manu-
facturer's recommendations, all ﬁlms were scanned in landscape
orientation in this study.
In Ref. [8], Arjomandy et al. recommend considering the average
of multiple readings of the same ﬁlm, in order to minimize lamp
warm-up dependence and to improve the signal to noise ratio. As
proposed by Saur et al. [3], we scanned every ﬁlm twice and
considered only the second reading for further analysis. Prior to
scanning session, ﬁve successive blank scans are taken for scanner
warm-up.
Regarding post exposure polymerization, we used a time period
of about 15 h between ﬁlm exposure and ﬁlm scanning, within a
time window of 2 h [10].
Treatment veriﬁcation using an independent electronic device
The Delta4 (ScandiDos AB, Uppsala, Sweden) electronic device
was used for patient-speciﬁc QA, in order to evaluate gamma
passing rates with another independent system. The Delta4 was
calibrated according tomanufacturer's recommendations, against a
Farmer type ionization chamber. The device was always positioned
at the machine isocentre (no longitudinal shift). Gamma evaluation
was performed in absolute mode.
Experiments
Scanner warm up and reproducibility
For both scanners, we quantiﬁed scanner warm up effects at two
dose levels (20 cGy and 300 cGy). We scanned EBT2 ﬁlm pieces,
batch A08171101A, in the central area of the scanner. The region of
interest (ROI) has a dimension of 1 in.1 in. (72 pixels 72 pixels).
Without any preview, we measured ten times consecutively the
mean pixel values in the ROI, in the three channels. To assess
scanner reproducibility at various dose levels, we scanned eight
times all ﬁlm pieces used for calibration (from 10 cGy to 360 cGy),
after proper warm up of the lamp, for both scanners. Following this
experiment, scanner reproducibility was assessed on regular basis
(more or less quarterly) by scanning eight times the control ﬁlms
exposed to a uniform dose (225 cGy).
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A frequently highlighted issue in early batches of EBT2 con-
cerned local heterogeneities due to manufacturing inconsistency,
leading to uncertainties in dose determination far beyond
commonly accepted tolerance levels [6]. We assessed intra-batch
homogeneity at zero dose only, scanning ﬁve EBT2 ﬁlms in the
central area of both scanners and ﬁve EBT3 ﬁlms using Epson
10000XL. To study intra-ﬁlm homogeneity, EBT2 and EBT3 ﬁlm
sheets were randomly selected and cut into eight pieces. In order to
mitigate inﬂuence of scanner reproducibility, results were averaged
over three readings. Finallywe compared, for EBT2 ﬁlms only, intra-
ﬁlm homogeneity at 0 cGy and 225 cGy.
Film calibration
Eight pieces out of a single ﬁlm sheet were exposed to
increasing dose levels (i.e. 10 cGy, 30 cGy, 60 cGy, 100 cGy, 150 cGy,
210 cGy, 280 cGy and 360 cGy) under reference conditions (100 cm
SAD, 10 cm depth in solid water, 10 cm2 ﬁeld size). Using FilmQA
Pro, the average PV is measured for all channels in a central 72 72
square pixel ROI, and a calibration function is ﬁtted onto the cali-
bration data points. In FilmQA Pro a variety of monotonic functions
is provided. As pointed out in Micke et al. [14], polynomial func-
tions are not recommended. FilmQA Pro provides users with
invertible functions whose extrapolated values asymptote to con-
stants, like the function “colour reciprocal linear vs dose”, in Eq. (1).
PVðDÞ ¼ aþ b
D c; (1)
where PV and D are pixel value and dose, respectively.
Application to patient speciﬁc QA
Absolute dose measurements were compared to Pinnacle cal-
culations, using the collapsed cone convolution/superposition
(CCC) algorithm and a 1-mm resolution in the coronal plane located
at the ﬁlm position. A noise ﬁlter was applied onto dose maps
generated in FilmQA Pro, since residual noise may lead to an
overestimation of gamma passing rates.
Head-and-neck patients are treated with simultaneously inte-
grated boost (SIB), typically 54e60e70 Gy in 30 fractions. For
prostate patients, hypofractionation results in prescribed dose up to
2.63 Gy per fraction. Our results are reported in terms of global
gamma index with 5 cGy dose difference (DD)/3 mm distance-to-
agreement (DTA) criteria. We decided to stick to this absolute
dose difference criterion since a percentage of maximum dose
would overestimate passing rates for integrated boost treatments.
We also perform a local gamma evaluation using 3% local dose
difference/3 mm DTA criteria, with an inferior threshold of 20 cGy.
Gamma analysis is manually restricted to a rectangular area
encompassing the apparent dose-induced darkening zone. The ROI
is positioned at least 5 mm from the ﬁlm edges. This means that for
large PTV, the gamma index evaluation is performed over a
15  15 cm2 area. In this study the “corrected red” dose map is the
only one we consider in multichannel evaluation.
Student t test was used for comparative analysis. Differences are
considered statistically signiﬁcant when p < 0.05.
Results
Scanner warm up. Scanner reproducibility
Scanner warm up effects are negligible, except in the blue
channel at low dose using the Epson V750. In this case, normalizedPV increased from 43.20 to 43.76 during warm up of the lamp (a
normalized PV of 100 indicates full transmission, i.e. raw PV of
65,535). In the red and green channels, the relative standard de-
viations of the ROI mean PV during warm up are below 0.1%, for
both scanners.
Regarding scanner reproducibility after proper warm up, we
obtained for both scanners standard deviations below 0.25% in the
blue channel and below 0.15% in the red and green channels. Using
control ﬁlms, we observed no drift over the lifetime of the scanners.
Intra-batch/intra-ﬁlm homogeneity
To illustrate intra-batch homogeneity at zero dose, the PV
standard deviations between ﬁlms from the same batch are shown
in Fig. 1.
As Epson V750 and Epson 10000XL present similar reproduc-
ibility, Fig. 1 shows that intra-batch homogeneity is better for the
most recent EBT2 batch (A08171101A), conﬁrming the improve-
ments claimed by the manufacturer. The measured batch homo-
geneity (averaged over three readings) lies within the range of
scanner reproducibility.
Intra-ﬁlm uniformity at zero dose is illustrated in Fig. 2. EBT3
(batch A03051205) uniformity is markedly degraded compared to
EBT2 ﬁlms.
Figures 1 and 2 show that intra-ﬁlm uniformity at zero dose for
EBT3 is poorer than intra-batch homogeneity measured in the
central region of ﬁlm sheets. From that we conclude that
manufacturing heterogeneities are prominent in the peripheral
parts of ﬁlm sheets for this batch.
Comparing EBT2 (batch A09271204) intra-ﬁlm homogeneity at
0 cGy and 225 cGy, we observed that relative standard deviations
were slightly lower at high dose. From this single experiment, we
assumed that ﬁlm homogeneity is not degraded in clinical dose
range, compared to results in Figs 1 and 2.
Film calibration
In Fig. 3 are shown calibration functions of the type “colour
reciprocal linear vs dose”, see Eq. (1).
The ﬁrst time we used EBT3 ﬁlms, none of the ﬁtting functions
available in FilmQA Pro (i.e. color reciprocal linear vs dose, rational
linear (quadratic, cubic) vs dose, and exponential universal) was
able to ﬁt the calibration data in the blue channel. Using another
EBT3 ﬁlm sheet, a new calibration was done and resulted in a good
ﬁt. We never observed this problem with EBT2 ﬁlms, whatever the
batch number. Further investigation, using more recent EBT3 ﬁlm
batches, is mandatory to draw any conclusion.
Patient speciﬁc QA
In Table 1 are shown passing rates for prostate (no lymph node
included) and head-and-neck patients, using landscape orientation
and Epson V750.
For head-and-neck patients more evaluation points failed the
gamma criteria. According to unpaired t test, differences between
ﬁlm batches are not signiﬁcant (p¼ 0.764 for prostate, p¼ 0.092 for
head-and-neck).
After two years of intensive use of the Epson V750 scanner (i.e.
around 5000 scans, including warm-up and experiments), we
observed a slight slope in raw PV proﬁles on the control ﬁlm pieces,
in the lamp direction. This slope suddenly appeared and was
prominent in the blue channel. Consequently we accelerated the
purchase of an A3-size Epson 10000XL scanner. This unwanted
behaviour of the scanner is discussed in the Discussion Section.
Figure 1. Intra-batch homogeneity of EBT2 and EBT3 ﬁlms, using both scanners.
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orientation are shown in Table 2. Single channel evaluation is
compared to multichannel (corrected red) correction algorithm.
We also compared global gamma index (5 cGy/3 mm criteria) to
local gamma index (3%/3 mm). All localized prostate patients un-
derwent VMAT treatments, while 35 out of 81 head-and-neck pa-
tients received step-and-shoot treatment, as well as 7 out of 16
pelvis patients.Figure 2. Intra-ﬁlm uniformity. Film 1e3: EBT2-A12171002B and Epson V750; ﬁlm 4e5: EBRegarding global passing rates, results are very similar between
single channel and multichannel evaluation. Using a paired t test,
we obtain two-tailed p values equal to 0.801, 0.372 and 0.615 for
respectively prostate, pelvis and head and neck patients. On the
other hand, multichannel evaluation presents better passing rates
with regard to local gamma index, with signiﬁcant p values
(p ¼ 0.016, 0.049 and 0.028 for prostate, pelvis and head and neck
patients, respectively). Local index criterion is more stringent thanT2-A08171101A and Epson 10000XL; ﬁlm 6e7: EBT3-A03051205 and Epson 10000XL.
Figure 3. Calibration functions of type “color reciprocal linear vs dose”. EBT2-A12171002B. Normalized PV (%) are plotted against dose (cGy).
M. Mathot et al. / Physica Medica 30 (2014) 871e877 875global index in “low” dose regions (in regions receiving less than
167 cGy). When considering VMAT and step-and-shoot patients
separately, no signiﬁcant difference appears (unpaired t test), either
for pelvis or head-and-neck patients. Average passing rates are very
close whatever the gamma criterion or the evaluation algorithm,
with no advantage for step-and-shoot versus VMAT.
As we used one single box of EBT3 ﬁlms, results are not shown
(thirteen patients only). Passing rates are slightly lower than those
displayed in Table 2.
When using multichannel approach we systematically veriﬁed
the consistency between the three colour channels. We observed
arithmetic consistency (i.e. average difference between corrected
doses in the three channels) between 1.5 cGy and 2.5 cGy, which is
consistent with expected values [14].
After one year of scanning with Epson 10000XL (around 3000
scans), we encountered the same problemwe observed with Epson
V750. Pixel value proﬁles in the lamp direction presented a gradual
tilting, resulting in a slope of many percents in dose using multi-
channel approach. In Fig. 4 are shown PV proﬁles in the lamp di-
rection (a) and corresponding corrected dose proﬁles (b), for a
control ﬁlm exposed to uniform radiation (225 cGy).
Discussion
Using the control ﬁlms irradiated with a square open ﬁeld prior
to patient measurement, progressive dysfunctions with both Epson
scanners were discovered (see Fig. 4 for Epson 10000XL). After one
(Epson 10000XL) or two (Epson V750) year(s) of use, a gradual
tilting of PV proﬁles in the lamp directionwas observed. This tiltingTable 1
Gamma passing rates for prostate (54 patients) and head-and-neck (43 patients),
using two EBT2 ﬁlm batches. Films scanned in landscape orientation with Epson
V750 and evaluated through multichannel correction algorithm. Agreement









Pass rate (%) 95.1 ± 3.9 88.1 ± 7.1 95.4 ± 3.5 92.44 ± 6.1is prominent in the blue channel, with normalized raw PV rising
from 36.5% to 37.5% over the ﬂat area of a 10-cm open ﬁeld, see
Fig. 4 (a). In the green and red (inweb version) channels, there is no
signiﬁcant tilting, with normalized PV within the range of mea-
surement uncertainty. The corrected dose maps in multichannel
analysis are signiﬁcantly impacted, despite the lower weight of the
blue channel in the algorithm. This lower weight of the blue
channel is a consequence of the shallow slope of the calibration
function in the blue channel, compared to the red and green (in
web version) curves (see Fig. 3 and Ref. [14]). Anyway the magni-
ﬁcation of the slope in terms of dose is mainly due to the slope of
the calibration functions, more sensitive in relative dose than in
relative PV.
This problem appeared suddenly, reinforced over time (during a
few weeks time) and then stabilized, for both scanners. Regrettably
consistency maps are unable to detect the problem, since dose
values between corrected channels remain very close.
Epson technical support (epson.fr) was not able to help us,
arguing that “their document scanners are not ofﬁcially designed
for irradiated ﬁlms digitalization”. The tilting is not visible in
reﬂection mode (reﬂection mode was used by Butson et al. in Ref.
[15], with good results), where the lamp is below the scanner bed.
In transmission mode, the working lamp is in the scanner lid
(optional transparency unit). Based on this, we think that the tilting
is mainly due to the transmission lamp. To verify these conclusions,
we plan to order a new transparency unit. To the best of our
knowledge, this undesirable behaviour has not been reported so farTable 2
Comparison of gamma passing rates for prostate (31 patients), pelvic (16 patients)
and head-and-neck patients (81 patients). Gamma criteria are 5 cGy-3 mm (global)
and 3 %-3 mm (local). EBT2 ﬁlms are scanned using Epson 10000XL in landscape
orientation. Batch numbers are A08171101A, F12170901A and A03221201.
Pass rates (%) Red channel Multichannel
Global Local Global Local
Prostate only 97.0 ± 2.9 93.1 ± 3.7 97.0 ± 2.6 94.3 ± 2.7
Pelvis 95.8 ± 3.0 95.0 ± 3.3 95.1 ± 4.4 96.0 ± 3.0
Head and neck 97.0 ± 3.5 94.0 ± 5.6 97.2 ± 3.0 95.2 ± 3.7
Figure 4. Multichannel correction for a ﬂat ﬁeld dose proﬁle. EBT2-A12171002B scanned with Epson 10000XL after one year of use. Normalized PV in % (a) and corrected dose
proﬁles in cGy (b) in the lamp direction.
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analysis.
As regards intra-sheet and intra-batch homogeneity, we
recommend the ﬁlm batch to be examined (at zero dose) before
clinical use, especially when early batches are considered.
Using the A4-size Epson V750, we obtained good passing rates
for prostate patients, for whom the region of interest is (roughly)
less than 10 cm. More discrepancies were observed for head-and-
neck patients (Table 1), due to the scanner lateral distortions. Us-
ing the A3-size Epson 10000XL (Table 2), gamma passing rates
were improved for head-and-neck patients, due to the better
spatial uniformity in the central area of the scanner bed [4].
Our comparative results between single channel evaluation and
triple channel method in FilmQA Pro conﬁrm a noticeable gain to
the beneﬁt of the latter, in terms of gamma passing rates. The
comparison between TPS calculations and measurements was also
based on a cross-calibrated CC13 IC (together with ﬁlm measure-
ments) and the Delta4. All patients considered, CC13 measure-
ments showed a slight underdosing (1.2% ± 0.7% (1 SD)). Using
Delta4, local gamma passing rates (3%/3 mm) were 97.9% ± 1.7%,
step-and-shoot treatments showing passing rates slightly higher
than VMAT. The 10-cm square beam irradiation (see Ref. [16] for
multichannel evaluation in standard conﬁguration), showed per-
fect agreement (100% passing rates) using control ﬁlms and Delta4,
except at ﬁeld edges from time to time. Based on these results, we
gained conﬁdence in TPS accuracy and (dynamic) beam delivery.
Higher local gamma passing rates obtained using multichannel
algorithm (closer to Delta4 results) suggest that some ﬁlm/scanner
artefacts are effectively mitigated compared to single channel
analysis.
Using one box of EBT3, we encountered difﬁculties we never
observed using many batches of EBT2, i.e. ﬁtting problems during
calibration and poorer intra-ﬁlm uniformity. Based on this limited
experience, we decided to stick to EBT2 ﬁlms for the future, keeping
in mind that similar dosimetric performance between EBT2 and
EBT3 was described in thorough publications [10,11].
In this study, no attempt was made to correct for the well-
documented dose-dependent non-uniform spatial response of
ﬂatbed scanners. Recent publications proposed elegant solutions to
this limitation, for example Girard et al. [13] and Crijns et al. [17].
These kinds of investigations are outside the scope of this work,
since our purpose is to report about our experience with
commercially available software and “plug and play” solution.
In addition to scanner reproducibility and ﬁlm homogeneity,
many uncertainties are involved in ﬁlm dosimetry. Interesting
discussion and analysis can be found in Refs. [7,18,19]. According to
[7,19], a global relative uncertainty of less than 3% can be achieved
in the central area of the scanner bed using our methodology.
Finally, physicists interested in starting ﬁlm dosimetry should be
aware of the time investment required. Film preparation (when
cutting is needed), ﬁlm setup (for every patient), ﬁlm scanning, ﬁlm
spatial registration and calibration of new batches are time
consuming. With no attempt to speed up the process (as in Ref.
[12]), the time needed per patient is around 30min, to be compared
to the 10 min needed using dedicated electronic devices offering
online readout and evaluation.
Conclusion
Radiochromic ﬁlms offer many unique features. There is no
other affordable detector providing sub-millimetre spatial resolu-
tion, no angular dependence and weak energy dependence. Based
on our experience, we can state that Gafchromic ﬁlms are reliablefor veriﬁcation of highly-modulated dose distributions. The ﬁlm
supplier has developed brand new software that streamlines and
optimizes PV conversion into dose and provides users with valu-
able warnings (consistency maps) for existing errors.
Nevertheless, in order to ensure sufﬁcient accuracy, extreme
caution is necessary when manipulating, irradiating and scanning
ﬁlms. Special attention should be given to the behaviour of the
scanner, since ﬁlm digitalization is by far the most critical step.
Commercial ﬂatbed scanners are not designed for ﬁlm dosimetry
and have to be used with great caution (ﬁxed location, stable
environmental conditions, informed users). It is mandatory to
monitor their performances on regular basis, to avoid major
discomﬁture. To our knowledge, this study is the ﬁrst to highlight
stochastic ageing artefacts for ﬂatbed scanners.Acknowledgements
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